Drug treatment based on pharmacogenomics, already a significant factor in oncology, psychiatry, pain management and anticoagulation therapy, is poised to play an important role in transplant medicine, a leading pharmacogenomics expert noted during the American College of Clinical Pharmacy 2020 virtual annual meeting.
The number of transplant patients who could benefit from personalized medicine is huge: one recent study found that 100% of nearly 900 organ transplant patients had at